**Executive Summary**
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, concluded a five-day National Capacity Building Training Programme. Held from 24th to 28th November 2025, the program aimed to strengthen national capabilities in quality assurance, standardization, and regulatory compliance within the ASU&H drug sector. The program targeted Drug Enforcement Officers, Quality Control Personnel, and drug manufacturers of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) drugs.
**Key Points / Main Content**
* **Training Program Overview:**
* The program was a comprehensive blend of expert lectures, demonstrations, and field visits.
* The program's objective was to strengthen national capabilities in quality assurance, standardization, and regulatory compliance in the ASU&H drug sector.
* **Technical Sessions and Visits:**
* The first two days featured technical sessions on NABL Accreditation, Quality Management Systems, Good Manufacturing Practices, and various evaluation and quality control aspects of herbal drugs.
* The third day included sessions on Shelf-life Studies and Regulatory Frameworks, followed by exposure visits to Dr. Willmar Schwabe India Pvt. Ltd. and Hamdard Laboratories.
* The fourth day concentrated on Microbiological and Pharmacological Evaluation, Regulatory Aspects, hands-on laboratory training, and a visit to an Herbal Garden.
* The final day covered Pharmacopoeia, Metal & Mineral Drug Standardization, and Modern Instrumentation used in ASU&H drug quality control.
* **Participants and Valedictory Session:**
* 37 participants from regulatory authorities, research councils, pharmaceutical industries, and academic institutions attended the program.
* The training enabled participants to gain first-hand knowledge on the latest advancements in quality testing and standardization practices.
* The valedictory session was graced by Prof. (Dr.) B. L. Mehra, Chairperson, National Commission for Indian System of Medicine, Ministry of Ayush, as Chief Guest, along with other dignitaries.
* **Outcomes and Appreciation:**
* Participants appreciated the combination of theoretical sessions, practical training, and field exposure.
* The initiative is expected to contribute to building a robust national quality assurance ecosystem for ASU&H drugs.
**Impact Analysis**
**Stakeholder:** Drug Enforcement Officers, Quality Control Personnel, and drug manufacturers of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) drugs.
* **Impact:** Increased understanding of Pharmacopoeial Standards, Good Manufacturing Practices, and related regulatory frameworks. Enhanced knowledge of quality testing and standardization practices.
* **Action Required:** Apply the acquired knowledge and skills to improve quality assurance, standardization, and regulatory compliance in the ASU&H drug sector.
**Stakeholder:** Regulatory Authorities
* **Impact:** Enhanced capabilities in regulating and overseeing the quality and standards of ASU&H drugs.
* **Action Required:** Utilize the gained insights to develop and enforce effective regulatory frameworks for the ASU&H drug sector.
Key Entities Referenced
ASU&H: Ayurveda, Siddha, Unani and Homoeopathy drugs
Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H): Commission responsible for quality standards in Indian medicine and Homoeopathy
Ministry of Ayush: Indian government ministry dealing with Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy
National Capacity Building Training Programme: A program aimed at improving quality assurance, standardization, and regulatory compliance in the ASU&H drug sector.
AYUSH
Pharmacopoeia Commission for Indian Medicine
& Homoeopathy Concludes Five-Day National
Capacity Building Training Programme for
ASU&H Stakeholders
प्रव तथ: 28 NOV 2025 8:40PM by PIB Delhi
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush,
successfully concluded a five-day National Capacity Building Training Programme for Drug Enforcement
Officers, Quality Control Personnel and drug manufacturers of Ayurveda, Siddha, Unani and
Homoeopathy (ASU&H) drugs. The programme was organized from 24th to 28th November 2025 with
the objective of strengthening national capabilities in quality assurance, standardization and regulatory
compliance in the ASU&H drug sector.
The training programme featured a comprehensive blend of expert lectures, demonstrations and field
visits. During the first two days, participants attended detailed technical sessions on NABL Accreditation,
Quality Management Systems, Good Manufacturing Practices, Pharmacognostic, Physico-chemical and
Phytochemical Evaluation and Quality Control of Herbal Drugs. On the third day, sessions on Shelf-life
Studies and Regulatory Frameworks were followed by exposure visits to leading manufacturing units
including Dr. Willmar Schwabe India Pvt. Ltd., Noida and Hamdard Laboratories, Ghaziabad. The fourth
day focused on Microbiological and Pharmacological Evaluation, Regulatory Aspects and hands-on
laboratory-based training, along with a visit to an Herbal Garden. The final day included lectures on
Pharmacopoeia, Metal & Mineral Drug Standardization and Modern Instrumentation used in ASU&H
drug quality control.
A total of 37 participants representing regulatory authorities, research councils, pharmaceutical industries
and academic institutions from across the country joined the programme. The training enabled participants
to gain first-hand knowledge on the latest advancements in quality testing and standardization practices
within the Indian traditional medicine sector.
The valedictory session was graced by Prof. (Dr.) B. L. Mehra, Chairperson, National Commission for
Indian System of Medicine, Ministry of Ayush, as Chief Guest. Also present were Dr. Jai Prakash, Senior
Principal Scientific Officer and Officer-in-Charge, Pharmacovigilance Programme of India (PvPI), Indian
Pharmacopoeia Commission; Dr. Ravinder Singh, Director, Food Safety and Standards Authority of India;
and Dr. Raman Mohan Singh, Director, PCIM&H. The dignitaries emphasized the significance of rigorous
quality control, global standards and scientific validation in strengthening the credibility and acceptance of
Indian traditional medicine systems.
Participants expressed high appreciation for the programme, noting that the combination of theoretical
sessions, practical training and field exposure greatly enhanced their understanding of Pharmacopoeial
Standards, Good Manufacturing Practices and related regulatory frameworks. The initiative is expected to
contribute significantly to the ongoing efforts toward building a robust national quality assurance
ecosystem for ASU&H drugs.***
(रलीज़ आईडी: 2196092) आगंतुक पटल : 387
इस वज्ञ को इन भाषाओ ंम पढ़: ही